Conjugated and deep vein thrombosis Patient Reports February 10, 2012



Conjugated Side Effects Report #4665424-6
Conjugated side effect was reported by a Pharmacist from on May 18, 2005. Female patient was diagnosed with artificial menopause and was treated with Conjugated. After drug was administered, patient experienced the following side effects: deep vein thrombosis What is  deep vein thrombosis. Conjugated dosage: 0.3MG DAILY ORAL. During the same period patient was treated with LORATADINE, MONTELUKAST, OMEPRAZOLE, FLUTICASONE, HYDROCHLOROTHIAZIDE, SIMVASTATIN, NAPROXEN, LORAZEPAM. Patient was hospitalized. Patient recovered.

Conjugated Side Effects Report #5583155-5
Conjugated side effect was reported by a Pharmacist from UNITED STATES on Jan 03, 2008. Female patient, 47 years of age, was treated with Conjugated. After drug was administered, patient experienced the following side effects: deep vein thrombosis What is  deep vein thrombosis, pulmonary embolism What is  pulmonary embolism. Conjugated dosage: unknown. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Conjugated